CLL
Conference Coverage
ASH: Donor CAR-T cells elicit responses in mixture of progressive B-cell cancers
Key clinical point: Allogeneic anti-CD19 CAR T-cell therapy showed promise in a treatment approach for B-cell malignancies persisting after...
News
Medical Roundtable: The Changing Pharmacologic Treatment Landscape in Chronic Lymphocytic Leukemia
News
Five epigenetic biomarkers define three CLL subgroups
Key clinical point: A new strategy allows CLL patients to be categorized into three epigenetic subgroups with differential clinicobiologic...
News
IgA increase linked to fewer infections in CLL patients on ibrutinib
Conference Coverage
MHM: Novel agents, combos show promise for relapsed/refractory CLL
Novel agents and combinations are showing great promise in relapsed/refractory CLL.
Conference Coverage
MHM: Novel agents, combos show promise for relapsed/refractory CLL
Novel agents and combinations are showing great promise in relapsed/refractory CLL.
Conference Coverage
CLL Therapy: Focus on comorbidities, not age
The majority of patients with chronic lymphocytic leukemia are elderly patients over age 65 years, which underscores the need for a careful...
Conference Coverage
CLL: No symptoms, no treatment still appropriate
Despite exciting new advances in the understanding of chronic lymphocytic leukemia, particularly with respect to prognostic features that predict...
News
HELIOS trial: Ibrutinib safely boosts survival in CLL/SLL
Adding ibrutinib to bendamustine and rituximab improved outcomes without significantly reducing safety in patients with chronic lymphocytic...
News
No evidence for CLL transmission via blood transfusion
Key clinical point: There is no evidence for higher risk of chronic lymphocytic leukemia (CLL) among recipients of blood products from donors who...
News
CLL exosomes promote stromal cell transition into cancer-associated fibroblasts
Key clinical point: Exosomes derived from chronic lymphocytic leukemia (CLL) cells induce stromal cell transition to cancer-associated fibroblasts...